Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome(Front. Oncol., (2021), 11, (682445), 10.3389/fonc.2021.682445)

ArticleOPEN ACCESS

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome(Front. Oncol., (2021), 11, (682445), 10.3389/fonc.2021.682445)

Frontiers in Oncology

DOI: 10.3389/fonc.2022.920342

0Citations

2Readers

Abstract

Due to a production error, there was a mistake in Table 2 as published. Some BRCA1 variants were incorrectly listed. The correct Table 2 appears below. The publisher apologizes for this mistake. The original version of this article has been updated.

Author supplied keywords

BRCA1
BRCA2
breast cancer
genetic testing
ovarian cancer
variants of uncertain significance (VUS)

Cite

CITATION STYLE

APA

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome(Front. Oncol., (2021), 11, (682445), 10.3389/fonc.2021.682445). (2022, May 4). Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.920342

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome(Front. Oncol., (2021), 11, (682445), 10.3389/fonc.2021.682445)

Abstract

Author supplied keywords

Cite

Register to see more suggestions